No Data
No Data
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
BofA Securities Maintains Canopy Growth(CGC.US) With Sell Rating, Cuts Target Price to $0.56
Insider Trades: Walmart, The Southern Company Among Notable Names This Week
This Week In Cannabis: Trump Policy Updates, Corporate Moves, Regulatory Shifts And Product Innovations
'Marijuana Rescheduling Isn't On The White House's New List Of Top Drug Policy Priorities Under The Trump Administration' - Marijuana Moment
Canopy Growth Launches Spectrum Reserve, A New Premium Medical Cannabis Brand In Canada